Previous close | 201.99 |
Open | 201.21 |
Bid | 202.43 x 300 |
Ask | 202.54 x 100 |
Day's range | 198.11 - 205.36 |
52-week range | 189.44 - 319.76 |
Volume | |
Avg. volume | 1,260,329 |
Market cap | 29.478B |
Beta (5Y monthly) | -0.01 |
PE ratio (TTM) | 25.31 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Insightful Analysis of Biogen Inc's Financials and Strategic Positioning
Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript April 24, 2024 Biogen Inc. misses on earnings expectations. Reported EPS is $3.3 EPS, expectations were $3.45. BIIB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Jennifer, […]